VALANX Biotech Appoints New Chief Scientific Officer VALANX Biotech, a biotech company, has appointed Klaus Orlinger, PhD, as Chief Scientific Officer to bolster its leadership team.
Danielle Smith: Balancing the Budget with Pipelines As part of the Financial Post's Red Ink series, Danielle Smith discusses the benefits …
Hong Kong Tennis Open: Last China Players Exit Zhang Shuai and Wang Yafan lost in straight sets, while top seed Belinda Bencic continues h…
Dewpoint Receives FDA Orphan Drug Designation for DPTX3186 Dewpoint Therapeutics has received the US FDA's Orphan Drug Designation (ODD) f…
Cumbria Firm Wins National Healthcare Award An Eden-based business, CCL Solutions, has been named Consultancy of the Year at the National …
Thursday's FTB: At Least the Jays Won I hope you didn't watch the Leafs game. The author watched the first period and a couple of minutes …
Sonny Jim's Legacy: A Fight for Justice After 16 years of delays, the fight for Sonny Jim becomes a battle against the system. Sonn…
Global Heating: How Vernacular Architecture is Affected by the Climate Crisis Vernacular architecture, often seen as a model for low-energ…
Siblings Bring Ancestral Weaving Traditions to Ralph Lauren Collection A resilient legacy of Diné weaving is now reaching homes across the…
AirAsia Parent Revives Nasdaq IPO Plan Capital A, the parent company of AirAsia, is reviving its plan to list a subsidiary on Nasdaq in 20…
Dutch Election Results The 2025 Dutch general election has concluded with nearly all votes counted, resulting in a tight competition betwe…